Global Influenza Drugs And Vaccines Market Research Report 2025(Status and Outlook)
Report Overview
The global Influenza Drugs And Vaccines market size was estimated at USD 21450.4 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza Drugs And Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza Drugs And Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza Drugs And Vaccines market
Global Influenza Drugs And Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL
Bristol Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Viatris
Hulan Bio
Changchun Institute of Biological
Jiangsu GDK
Sinovac
Beike Bio
Market Segmentation (by Type)
Influenza Drugs
Influenza Vaccines
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Drugs And Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza Drugs And Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Influenza Drugs And Vaccines market size was estimated at USD 21450.4 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.85% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Influenza Drugs And Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Influenza Drugs And Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Influenza Drugs And Vaccines market
Global Influenza Drugs And Vaccines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
CSL
Bristol Myers Squibb
AstraZeneca
Eli Lilly
Roche
GlaxoSmithKline
Novartis
Pfizer
Sanofi
Bayer
Celgene
Seqirus
Protein Sciences Corporation
Serum Institute of India
Emergent Biosolutions
BioCryst Pharmaceuticals
Alvogen
Viatris
Hulan Bio
Changchun Institute of Biological
Jiangsu GDK
Sinovac
Beike Bio
Market Segmentation (by Type)
Influenza Drugs
Influenza Vaccines
Market Segmentation (by Application)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Influenza Drugs And Vaccines Market
- Overview of the regional outlook of the Influenza Drugs And Vaccines Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Influenza Drugs And Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Influenza Drugs And Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Influenza Drugs And Vaccines
1.2 Key Market Segments
1.2.1 Influenza Drugs And Vaccines Segment by Type
1.2.2 Influenza Drugs And Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA DRUGS AND VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Drugs And Vaccines Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Influenza Drugs And Vaccines Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA DRUGS AND VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza Drugs And Vaccines Product Life Cycle
3.3 Global Influenza Drugs And Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Influenza Drugs And Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Drugs And Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Drugs And Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza Drugs And Vaccines Market Competitive Situation and Trends
3.8.1 Influenza Drugs And Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Drugs And Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA DRUGS AND VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Influenza Drugs And Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA DRUGS AND VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Drugs And Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza Drugs And Vaccines Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA DRUGS AND VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Drugs And Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Influenza Drugs And Vaccines Market Size Market Share by Type (2020-2025)
6.4 Global Influenza Drugs And Vaccines Price by Type (2020-2025)
7 INFLUENZA DRUGS AND VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Drugs And Vaccines Market Sales by Application (2020-2025)
7.3 Global Influenza Drugs And Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Drugs And Vaccines Sales Growth Rate by Application (2020-2025)
8 INFLUENZA DRUGS AND VACCINES MARKET SALES BY REGION
8.1 Global Influenza Drugs And Vaccines Sales by Region
8.1.1 Global Influenza Drugs And Vaccines Sales by Region
8.1.2 Global Influenza Drugs And Vaccines Sales Market Share by Region
8.2 Global Influenza Drugs And Vaccines Market Size by Region
8.2.1 Global Influenza Drugs And Vaccines Market Size by Region
8.2.2 Global Influenza Drugs And Vaccines Market Size Market Share by Region
8.3 North America
8.3.1 North America Influenza Drugs And Vaccines Sales by Country
8.3.2 North America Influenza Drugs And Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza Drugs And Vaccines Sales by Country
8.4.2 Europe Influenza Drugs And Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza Drugs And Vaccines Sales by Region
8.5.2 Asia Pacific Influenza Drugs And Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza Drugs And Vaccines Sales by Country
8.6.2 South America Influenza Drugs And Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza Drugs And Vaccines Sales by Region
8.7.2 Middle East and Africa Influenza Drugs And Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA DRUGS AND VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza Drugs And Vaccines by Region(2020-2025)
9.2 Global Influenza Drugs And Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Drugs And Vaccines Production
9.4.1 North America Influenza Drugs And Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Drugs And Vaccines Production
9.5.1 Europe Influenza Drugs And Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Drugs And Vaccines Production (2020-2025)
9.6.1 Japan Influenza Drugs And Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Drugs And Vaccines Production (2020-2025)
9.7.1 China Influenza Drugs And Vaccines Production Growth Rate (2020-2025)
9.7.2 China Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL
10.1.1 CSL Basic Information
10.1.2 CSL Influenza Drugs And Vaccines Product Overview
10.1.3 CSL Influenza Drugs And Vaccines Product Market Performance
10.1.4 CSL Business Overview
10.1.5 CSL SWOT Analysis
10.1.6 CSL Recent Developments
10.2 Bristol Myers Squibb
10.2.1 Bristol Myers Squibb Basic Information
10.2.2 Bristol Myers Squibb Influenza Drugs And Vaccines Product Overview
10.2.3 Bristol Myers Squibb Influenza Drugs And Vaccines Product Market Performance
10.2.4 Bristol Myers Squibb Business Overview
10.2.5 Bristol Myers Squibb SWOT Analysis
10.2.6 Bristol Myers Squibb Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Basic Information
10.3.2 AstraZeneca Influenza Drugs And Vaccines Product Overview
10.3.3 AstraZeneca Influenza Drugs And Vaccines Product Market Performance
10.3.4 AstraZeneca Business Overview
10.3.5 AstraZeneca SWOT Analysis
10.3.6 AstraZeneca Recent Developments
10.4 Eli Lilly
10.4.1 Eli Lilly Basic Information
10.4.2 Eli Lilly Influenza Drugs And Vaccines Product Overview
10.4.3 Eli Lilly Influenza Drugs And Vaccines Product Market Performance
10.4.4 Eli Lilly Business Overview
10.4.5 Eli Lilly Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Influenza Drugs And Vaccines Product Overview
10.5.3 Roche Influenza Drugs And Vaccines Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Basic Information
10.6.2 GlaxoSmithKline Influenza Drugs And Vaccines Product Overview
10.6.3 GlaxoSmithKline Influenza Drugs And Vaccines Product Market Performance
10.6.4 GlaxoSmithKline Business Overview
10.6.5 GlaxoSmithKline Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Influenza Drugs And Vaccines Product Overview
10.7.3 Novartis Influenza Drugs And Vaccines Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer Influenza Drugs And Vaccines Product Overview
10.8.3 Pfizer Influenza Drugs And Vaccines Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 Sanofi
10.9.1 Sanofi Basic Information
10.9.2 Sanofi Influenza Drugs And Vaccines Product Overview
10.9.3 Sanofi Influenza Drugs And Vaccines Product Market Performance
10.9.4 Sanofi Business Overview
10.9.5 Sanofi Recent Developments
10.10 Bayer
10.10.1 Bayer Basic Information
10.10.2 Bayer Influenza Drugs And Vaccines Product Overview
10.10.3 Bayer Influenza Drugs And Vaccines Product Market Performance
10.10.4 Bayer Business Overview
10.10.5 Bayer Recent Developments
10.11 Celgene
10.11.1 Celgene Basic Information
10.11.2 Celgene Influenza Drugs And Vaccines Product Overview
10.11.3 Celgene Influenza Drugs And Vaccines Product Market Performance
10.11.4 Celgene Business Overview
10.11.5 Celgene Recent Developments
10.12 Seqirus
10.12.1 Seqirus Basic Information
10.12.2 Seqirus Influenza Drugs And Vaccines Product Overview
10.12.3 Seqirus Influenza Drugs And Vaccines Product Market Performance
10.12.4 Seqirus Business Overview
10.12.5 Seqirus Recent Developments
10.13 Protein Sciences Corporation
10.13.1 Protein Sciences Corporation Basic Information
10.13.2 Protein Sciences Corporation Influenza Drugs And Vaccines Product Overview
10.13.3 Protein Sciences Corporation Influenza Drugs And Vaccines Product Market Performance
10.13.4 Protein Sciences Corporation Business Overview
10.13.5 Protein Sciences Corporation Recent Developments
10.14 Serum Institute of India
10.14.1 Serum Institute of India Basic Information
10.14.2 Serum Institute of India Influenza Drugs And Vaccines Product Overview
10.14.3 Serum Institute of India Influenza Drugs And Vaccines Product Market Performance
10.14.4 Serum Institute of India Business Overview
10.14.5 Serum Institute of India Recent Developments
10.15 Emergent Biosolutions
10.15.1 Emergent Biosolutions Basic Information
10.15.2 Emergent Biosolutions Influenza Drugs And Vaccines Product Overview
10.15.3 Emergent Biosolutions Influenza Drugs And Vaccines Product Market Performance
10.15.4 Emergent Biosolutions Business Overview
10.15.5 Emergent Biosolutions Recent Developments
10.16 BioCryst Pharmaceuticals
10.16.1 BioCryst Pharmaceuticals Basic Information
10.16.2 BioCryst Pharmaceuticals Influenza Drugs And Vaccines Product Overview
10.16.3 BioCryst Pharmaceuticals Influenza Drugs And Vaccines Product Market Performance
10.16.4 BioCryst Pharmaceuticals Business Overview
10.16.5 BioCryst Pharmaceuticals Recent Developments
10.17 Alvogen
10.17.1 Alvogen Basic Information
10.17.2 Alvogen Influenza Drugs And Vaccines Product Overview
10.17.3 Alvogen Influenza Drugs And Vaccines Product Market Performance
10.17.4 Alvogen Business Overview
10.17.5 Alvogen Recent Developments
10.18 Viatris
10.18.1 Viatris Basic Information
10.18.2 Viatris Influenza Drugs And Vaccines Product Overview
10.18.3 Viatris Influenza Drugs And Vaccines Product Market Performance
10.18.4 Viatris Business Overview
10.18.5 Viatris Recent Developments
10.19 Hulan Bio
10.19.1 Hulan Bio Basic Information
10.19.2 Hulan Bio Influenza Drugs And Vaccines Product Overview
10.19.3 Hulan Bio Influenza Drugs And Vaccines Product Market Performance
10.19.4 Hulan Bio Business Overview
10.19.5 Hulan Bio Recent Developments
10.20 Changchun Institute of Biological
10.20.1 Changchun Institute of Biological Basic Information
10.20.2 Changchun Institute of Biological Influenza Drugs And Vaccines Product Overview
10.20.3 Changchun Institute of Biological Influenza Drugs And Vaccines Product Market Performance
10.20.4 Changchun Institute of Biological Business Overview
10.20.5 Changchun Institute of Biological Recent Developments
10.21 Jiangsu GDK
10.21.1 Jiangsu GDK Basic Information
10.21.2 Jiangsu GDK Influenza Drugs And Vaccines Product Overview
10.21.3 Jiangsu GDK Influenza Drugs And Vaccines Product Market Performance
10.21.4 Jiangsu GDK Business Overview
10.21.5 Jiangsu GDK Recent Developments
10.22 Sinovac
10.22.1 Sinovac Basic Information
10.22.2 Sinovac Influenza Drugs And Vaccines Product Overview
10.22.3 Sinovac Influenza Drugs And Vaccines Product Market Performance
10.22.4 Sinovac Business Overview
10.22.5 Sinovac Recent Developments
10.23 Beike Bio
10.23.1 Beike Bio Basic Information
10.23.2 Beike Bio Influenza Drugs And Vaccines Product Overview
10.23.3 Beike Bio Influenza Drugs And Vaccines Product Market Performance
10.23.4 Beike Bio Business Overview
10.23.5 Beike Bio Recent Developments
11 INFLUENZA DRUGS AND VACCINES MARKET FORECAST BY REGION
11.1 Global Influenza Drugs And Vaccines Market Size Forecast
11.2 Global Influenza Drugs And Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza Drugs And Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Influenza Drugs And Vaccines Market Size Forecast by Region
11.2.4 South America Influenza Drugs And Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza Drugs And Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Influenza Drugs And Vaccines Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Influenza Drugs And Vaccines by Type (2026-2033)
12.1.2 Global Influenza Drugs And Vaccines Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Influenza Drugs And Vaccines by Type (2026-2033)
12.2 Global Influenza Drugs And Vaccines Market Forecast by Application (2026-2033)
12.2.1 Global Influenza Drugs And Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Influenza Drugs And Vaccines Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Influenza Drugs And Vaccines
1.2 Key Market Segments
1.2.1 Influenza Drugs And Vaccines Segment by Type
1.2.2 Influenza Drugs And Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INFLUENZA DRUGS AND VACCINES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Influenza Drugs And Vaccines Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Influenza Drugs And Vaccines Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INFLUENZA DRUGS AND VACCINES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Influenza Drugs And Vaccines Product Life Cycle
3.3 Global Influenza Drugs And Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Influenza Drugs And Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Influenza Drugs And Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Influenza Drugs And Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Influenza Drugs And Vaccines Market Competitive Situation and Trends
3.8.1 Influenza Drugs And Vaccines Market Concentration Rate
3.8.2 Global 5 and 10 Largest Influenza Drugs And Vaccines Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INFLUENZA DRUGS AND VACCINES INDUSTRY CHAIN ANALYSIS
4.1 Influenza Drugs And Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INFLUENZA DRUGS AND VACCINES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Influenza Drugs And Vaccines Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Influenza Drugs And Vaccines Market
5.7 ESG Ratings of Leading Companies
6 INFLUENZA DRUGS AND VACCINES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Influenza Drugs And Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Influenza Drugs And Vaccines Market Size Market Share by Type (2020-2025)
6.4 Global Influenza Drugs And Vaccines Price by Type (2020-2025)
7 INFLUENZA DRUGS AND VACCINES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Influenza Drugs And Vaccines Market Sales by Application (2020-2025)
7.3 Global Influenza Drugs And Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Influenza Drugs And Vaccines Sales Growth Rate by Application (2020-2025)
8 INFLUENZA DRUGS AND VACCINES MARKET SALES BY REGION
8.1 Global Influenza Drugs And Vaccines Sales by Region
8.1.1 Global Influenza Drugs And Vaccines Sales by Region
8.1.2 Global Influenza Drugs And Vaccines Sales Market Share by Region
8.2 Global Influenza Drugs And Vaccines Market Size by Region
8.2.1 Global Influenza Drugs And Vaccines Market Size by Region
8.2.2 Global Influenza Drugs And Vaccines Market Size Market Share by Region
8.3 North America
8.3.1 North America Influenza Drugs And Vaccines Sales by Country
8.3.2 North America Influenza Drugs And Vaccines Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Influenza Drugs And Vaccines Sales by Country
8.4.2 Europe Influenza Drugs And Vaccines Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Influenza Drugs And Vaccines Sales by Region
8.5.2 Asia Pacific Influenza Drugs And Vaccines Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Influenza Drugs And Vaccines Sales by Country
8.6.2 South America Influenza Drugs And Vaccines Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Influenza Drugs And Vaccines Sales by Region
8.7.2 Middle East and Africa Influenza Drugs And Vaccines Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INFLUENZA DRUGS AND VACCINES MARKET PRODUCTION BY REGION
9.1 Global Production of Influenza Drugs And Vaccines by Region(2020-2025)
9.2 Global Influenza Drugs And Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Influenza Drugs And Vaccines Production
9.4.1 North America Influenza Drugs And Vaccines Production Growth Rate (2020-2025)
9.4.2 North America Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Influenza Drugs And Vaccines Production
9.5.1 Europe Influenza Drugs And Vaccines Production Growth Rate (2020-2025)
9.5.2 Europe Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Influenza Drugs And Vaccines Production (2020-2025)
9.6.1 Japan Influenza Drugs And Vaccines Production Growth Rate (2020-2025)
9.6.2 Japan Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Influenza Drugs And Vaccines Production (2020-2025)
9.7.1 China Influenza Drugs And Vaccines Production Growth Rate (2020-2025)
9.7.2 China Influenza Drugs And Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 CSL
10.1.1 CSL Basic Information
10.1.2 CSL Influenza Drugs And Vaccines Product Overview
10.1.3 CSL Influenza Drugs And Vaccines Product Market Performance
10.1.4 CSL Business Overview
10.1.5 CSL SWOT Analysis
10.1.6 CSL Recent Developments
10.2 Bristol Myers Squibb
10.2.1 Bristol Myers Squibb Basic Information
10.2.2 Bristol Myers Squibb Influenza Drugs And Vaccines Product Overview
10.2.3 Bristol Myers Squibb Influenza Drugs And Vaccines Product Market Performance
10.2.4 Bristol Myers Squibb Business Overview
10.2.5 Bristol Myers Squibb SWOT Analysis
10.2.6 Bristol Myers Squibb Recent Developments
10.3 AstraZeneca
10.3.1 AstraZeneca Basic Information
10.3.2 AstraZeneca Influenza Drugs And Vaccines Product Overview
10.3.3 AstraZeneca Influenza Drugs And Vaccines Product Market Performance
10.3.4 AstraZeneca Business Overview
10.3.5 AstraZeneca SWOT Analysis
10.3.6 AstraZeneca Recent Developments
10.4 Eli Lilly
10.4.1 Eli Lilly Basic Information
10.4.2 Eli Lilly Influenza Drugs And Vaccines Product Overview
10.4.3 Eli Lilly Influenza Drugs And Vaccines Product Market Performance
10.4.4 Eli Lilly Business Overview
10.4.5 Eli Lilly Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Influenza Drugs And Vaccines Product Overview
10.5.3 Roche Influenza Drugs And Vaccines Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Basic Information
10.6.2 GlaxoSmithKline Influenza Drugs And Vaccines Product Overview
10.6.3 GlaxoSmithKline Influenza Drugs And Vaccines Product Market Performance
10.6.4 GlaxoSmithKline Business Overview
10.6.5 GlaxoSmithKline Recent Developments
10.7 Novartis
10.7.1 Novartis Basic Information
10.7.2 Novartis Influenza Drugs And Vaccines Product Overview
10.7.3 Novartis Influenza Drugs And Vaccines Product Market Performance
10.7.4 Novartis Business Overview
10.7.5 Novartis Recent Developments
10.8 Pfizer
10.8.1 Pfizer Basic Information
10.8.2 Pfizer Influenza Drugs And Vaccines Product Overview
10.8.3 Pfizer Influenza Drugs And Vaccines Product Market Performance
10.8.4 Pfizer Business Overview
10.8.5 Pfizer Recent Developments
10.9 Sanofi
10.9.1 Sanofi Basic Information
10.9.2 Sanofi Influenza Drugs And Vaccines Product Overview
10.9.3 Sanofi Influenza Drugs And Vaccines Product Market Performance
10.9.4 Sanofi Business Overview
10.9.5 Sanofi Recent Developments
10.10 Bayer
10.10.1 Bayer Basic Information
10.10.2 Bayer Influenza Drugs And Vaccines Product Overview
10.10.3 Bayer Influenza Drugs And Vaccines Product Market Performance
10.10.4 Bayer Business Overview
10.10.5 Bayer Recent Developments
10.11 Celgene
10.11.1 Celgene Basic Information
10.11.2 Celgene Influenza Drugs And Vaccines Product Overview
10.11.3 Celgene Influenza Drugs And Vaccines Product Market Performance
10.11.4 Celgene Business Overview
10.11.5 Celgene Recent Developments
10.12 Seqirus
10.12.1 Seqirus Basic Information
10.12.2 Seqirus Influenza Drugs And Vaccines Product Overview
10.12.3 Seqirus Influenza Drugs And Vaccines Product Market Performance
10.12.4 Seqirus Business Overview
10.12.5 Seqirus Recent Developments
10.13 Protein Sciences Corporation
10.13.1 Protein Sciences Corporation Basic Information
10.13.2 Protein Sciences Corporation Influenza Drugs And Vaccines Product Overview
10.13.3 Protein Sciences Corporation Influenza Drugs And Vaccines Product Market Performance
10.13.4 Protein Sciences Corporation Business Overview
10.13.5 Protein Sciences Corporation Recent Developments
10.14 Serum Institute of India
10.14.1 Serum Institute of India Basic Information
10.14.2 Serum Institute of India Influenza Drugs And Vaccines Product Overview
10.14.3 Serum Institute of India Influenza Drugs And Vaccines Product Market Performance
10.14.4 Serum Institute of India Business Overview
10.14.5 Serum Institute of India Recent Developments
10.15 Emergent Biosolutions
10.15.1 Emergent Biosolutions Basic Information
10.15.2 Emergent Biosolutions Influenza Drugs And Vaccines Product Overview
10.15.3 Emergent Biosolutions Influenza Drugs And Vaccines Product Market Performance
10.15.4 Emergent Biosolutions Business Overview
10.15.5 Emergent Biosolutions Recent Developments
10.16 BioCryst Pharmaceuticals
10.16.1 BioCryst Pharmaceuticals Basic Information
10.16.2 BioCryst Pharmaceuticals Influenza Drugs And Vaccines Product Overview
10.16.3 BioCryst Pharmaceuticals Influenza Drugs And Vaccines Product Market Performance
10.16.4 BioCryst Pharmaceuticals Business Overview
10.16.5 BioCryst Pharmaceuticals Recent Developments
10.17 Alvogen
10.17.1 Alvogen Basic Information
10.17.2 Alvogen Influenza Drugs And Vaccines Product Overview
10.17.3 Alvogen Influenza Drugs And Vaccines Product Market Performance
10.17.4 Alvogen Business Overview
10.17.5 Alvogen Recent Developments
10.18 Viatris
10.18.1 Viatris Basic Information
10.18.2 Viatris Influenza Drugs And Vaccines Product Overview
10.18.3 Viatris Influenza Drugs And Vaccines Product Market Performance
10.18.4 Viatris Business Overview
10.18.5 Viatris Recent Developments
10.19 Hulan Bio
10.19.1 Hulan Bio Basic Information
10.19.2 Hulan Bio Influenza Drugs And Vaccines Product Overview
10.19.3 Hulan Bio Influenza Drugs And Vaccines Product Market Performance
10.19.4 Hulan Bio Business Overview
10.19.5 Hulan Bio Recent Developments
10.20 Changchun Institute of Biological
10.20.1 Changchun Institute of Biological Basic Information
10.20.2 Changchun Institute of Biological Influenza Drugs And Vaccines Product Overview
10.20.3 Changchun Institute of Biological Influenza Drugs And Vaccines Product Market Performance
10.20.4 Changchun Institute of Biological Business Overview
10.20.5 Changchun Institute of Biological Recent Developments
10.21 Jiangsu GDK
10.21.1 Jiangsu GDK Basic Information
10.21.2 Jiangsu GDK Influenza Drugs And Vaccines Product Overview
10.21.3 Jiangsu GDK Influenza Drugs And Vaccines Product Market Performance
10.21.4 Jiangsu GDK Business Overview
10.21.5 Jiangsu GDK Recent Developments
10.22 Sinovac
10.22.1 Sinovac Basic Information
10.22.2 Sinovac Influenza Drugs And Vaccines Product Overview
10.22.3 Sinovac Influenza Drugs And Vaccines Product Market Performance
10.22.4 Sinovac Business Overview
10.22.5 Sinovac Recent Developments
10.23 Beike Bio
10.23.1 Beike Bio Basic Information
10.23.2 Beike Bio Influenza Drugs And Vaccines Product Overview
10.23.3 Beike Bio Influenza Drugs And Vaccines Product Market Performance
10.23.4 Beike Bio Business Overview
10.23.5 Beike Bio Recent Developments
11 INFLUENZA DRUGS AND VACCINES MARKET FORECAST BY REGION
11.1 Global Influenza Drugs And Vaccines Market Size Forecast
11.2 Global Influenza Drugs And Vaccines Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Influenza Drugs And Vaccines Market Size Forecast by Country
11.2.3 Asia Pacific Influenza Drugs And Vaccines Market Size Forecast by Region
11.2.4 South America Influenza Drugs And Vaccines Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Influenza Drugs And Vaccines by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Influenza Drugs And Vaccines Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Influenza Drugs And Vaccines by Type (2026-2033)
12.1.2 Global Influenza Drugs And Vaccines Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Influenza Drugs And Vaccines by Type (2026-2033)
12.2 Global Influenza Drugs And Vaccines Market Forecast by Application (2026-2033)
12.2.1 Global Influenza Drugs And Vaccines Sales (K MT) Forecast by Application
12.2.2 Global Influenza Drugs And Vaccines Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Drugs And Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Influenza Drugs And Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Influenza Drugs And Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Influenza Drugs And Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Influenza Drugs And Vaccines Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs And Vaccines as of 2024)
Table 10. Global Market Influenza Drugs And Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Influenza Drugs And Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Influenza Drugs And Vaccines Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Influenza Drugs And Vaccines Sales by Type (K MT)
Table 26. Global Influenza Drugs And Vaccines Market Size by Type (M USD)
Table 27. Global Influenza Drugs And Vaccines Sales (K MT) by Type (2020-2025)
Table 28. Global Influenza Drugs And Vaccines Sales Market Share by Type (2020-2025)
Table 29. Global Influenza Drugs And Vaccines Market Size (M USD) by Type (2020-2025)
Table 30. Global Influenza Drugs And Vaccines Market Size Share by Type (2020-2025)
Table 31. Global Influenza Drugs And Vaccines Price (USD/KG) by Type (2020-2025)
Table 32. Global Influenza Drugs And Vaccines Sales (K MT) by Application
Table 33. Global Influenza Drugs And Vaccines Market Size by Application
Table 34. Global Influenza Drugs And Vaccines Sales by Application (2020-2025) & (K MT)
Table 35. Global Influenza Drugs And Vaccines Sales Market Share by Application (2020-2025)
Table 36. Global Influenza Drugs And Vaccines Market Size by Application (2020-2025) & (M USD)
Table 37. Global Influenza Drugs And Vaccines Market Share by Application (2020-2025)
Table 38. Global Influenza Drugs And Vaccines Sales Growth Rate by Application (2020-2025)
Table 39. Global Influenza Drugs And Vaccines Sales by Region (2020-2025) & (K MT)
Table 40. Global Influenza Drugs And Vaccines Sales Market Share by Region (2020-2025)
Table 41. Global Influenza Drugs And Vaccines Market Size by Region (2020-2025) & (M USD)
Table 42. Global Influenza Drugs And Vaccines Market Size Market Share by Region (2020-2025)
Table 43. North America Influenza Drugs And Vaccines Sales by Country (2020-2025) & (K MT)
Table 44. North America Influenza Drugs And Vaccines Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Influenza Drugs And Vaccines Sales by Country (2020-2025) & (K MT)
Table 46. Europe Influenza Drugs And Vaccines Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Influenza Drugs And Vaccines Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Influenza Drugs And Vaccines Market Size by Region (2020-2025) & (M USD)
Table 49. South America Influenza Drugs And Vaccines Sales by Country (2020-2025) & (K MT)
Table 50. South America Influenza Drugs And Vaccines Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Influenza Drugs And Vaccines Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Influenza Drugs And Vaccines Market Size by Region (2020-2025) & (M USD)
Table 53. Global Influenza Drugs And Vaccines Production (K MT) by Region(2020-2025)
Table 54. Global Influenza Drugs And Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Influenza Drugs And Vaccines Revenue Market Share by Region (2020-2025)
Table 56. Global Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. CSL Basic Information
Table 62. CSL Influenza Drugs And Vaccines Product Overview
Table 63. CSL Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. CSL Business Overview
Table 65. CSL SWOT Analysis
Table 66. CSL Recent Developments
Table 67. Bristol Myers Squibb Basic Information
Table 68. Bristol Myers Squibb Influenza Drugs And Vaccines Product Overview
Table 69. Bristol Myers Squibb Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Bristol Myers Squibb Business Overview
Table 71. Bristol Myers Squibb SWOT Analysis
Table 72. Bristol Myers Squibb Recent Developments
Table 73. AstraZeneca Basic Information
Table 74. AstraZeneca Influenza Drugs And Vaccines Product Overview
Table 75. AstraZeneca Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. AstraZeneca Business Overview
Table 77. AstraZeneca SWOT Analysis
Table 78. AstraZeneca Recent Developments
Table 79. Eli Lilly Basic Information
Table 80. Eli Lilly Influenza Drugs And Vaccines Product Overview
Table 81. Eli Lilly Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Recent Developments
Table 84. Roche Basic Information
Table 85. Roche Influenza Drugs And Vaccines Product Overview
Table 86. Roche Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Roche Business Overview
Table 88. Roche Recent Developments
Table 89. GlaxoSmithKline Basic Information
Table 90. GlaxoSmithKline Influenza Drugs And Vaccines Product Overview
Table 91. GlaxoSmithKline Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Recent Developments
Table 94. Novartis Basic Information
Table 95. Novartis Influenza Drugs And Vaccines Product Overview
Table 96. Novartis Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Novartis Business Overview
Table 98. Novartis Recent Developments
Table 99. Pfizer Basic Information
Table 100. Pfizer Influenza Drugs And Vaccines Product Overview
Table 101. Pfizer Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. Sanofi Basic Information
Table 105. Sanofi Influenza Drugs And Vaccines Product Overview
Table 106. Sanofi Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Sanofi Business Overview
Table 108. Sanofi Recent Developments
Table 109. Bayer Basic Information
Table 110. Bayer Influenza Drugs And Vaccines Product Overview
Table 111. Bayer Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Bayer Business Overview
Table 113. Bayer Recent Developments
Table 114. Celgene Basic Information
Table 115. Celgene Influenza Drugs And Vaccines Product Overview
Table 116. Celgene Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Celgene Business Overview
Table 118. Celgene Recent Developments
Table 119. Seqirus Basic Information
Table 120. Seqirus Influenza Drugs And Vaccines Product Overview
Table 121. Seqirus Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Seqirus Business Overview
Table 123. Seqirus Recent Developments
Table 124. Protein Sciences Corporation Basic Information
Table 125. Protein Sciences Corporation Influenza Drugs And Vaccines Product Overview
Table 126. Protein Sciences Corporation Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Protein Sciences Corporation Business Overview
Table 128. Protein Sciences Corporation Recent Developments
Table 129. Serum Institute of India Basic Information
Table 130. Serum Institute of India Influenza Drugs And Vaccines Product Overview
Table 131. Serum Institute of India Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Serum Institute of India Business Overview
Table 133. Serum Institute of India Recent Developments
Table 134. Emergent Biosolutions Basic Information
Table 135. Emergent Biosolutions Influenza Drugs And Vaccines Product Overview
Table 136. Emergent Biosolutions Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Emergent Biosolutions Business Overview
Table 138. Emergent Biosolutions Recent Developments
Table 139. BioCryst Pharmaceuticals Basic Information
Table 140. BioCryst Pharmaceuticals Influenza Drugs And Vaccines Product Overview
Table 141. BioCryst Pharmaceuticals Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. BioCryst Pharmaceuticals Business Overview
Table 143. BioCryst Pharmaceuticals Recent Developments
Table 144. Alvogen Basic Information
Table 145. Alvogen Influenza Drugs And Vaccines Product Overview
Table 146. Alvogen Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Alvogen Business Overview
Table 148. Alvogen Recent Developments
Table 149. Viatris Basic Information
Table 150. Viatris Influenza Drugs And Vaccines Product Overview
Table 151. Viatris Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Viatris Business Overview
Table 153. Viatris Recent Developments
Table 154. Hulan Bio Basic Information
Table 155. Hulan Bio Influenza Drugs And Vaccines Product Overview
Table 156. Hulan Bio Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 157. Hulan Bio Business Overview
Table 158. Hulan Bio Recent Developments
Table 159. Changchun Institute of Biological Basic Information
Table 160. Changchun Institute of Biological Influenza Drugs And Vaccines Product Overview
Table 161. Changchun Institute of Biological Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 162. Changchun Institute of Biological Business Overview
Table 163. Changchun Institute of Biological Recent Developments
Table 164. Jiangsu GDK Basic Information
Table 165. Jiangsu GDK Influenza Drugs And Vaccines Product Overview
Table 166. Jiangsu GDK Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 167. Jiangsu GDK Business Overview
Table 168. Jiangsu GDK Recent Developments
Table 169. Sinovac Basic Information
Table 170. Sinovac Influenza Drugs And Vaccines Product Overview
Table 171. Sinovac Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 172. Sinovac Business Overview
Table 173. Sinovac Recent Developments
Table 174. Beike Bio Basic Information
Table 175. Beike Bio Influenza Drugs And Vaccines Product Overview
Table 176. Beike Bio Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 177. Beike Bio Business Overview
Table 178. Beike Bio Recent Developments
Table 179. Global Influenza Drugs And Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 180. Global Influenza Drugs And Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 181. North America Influenza Drugs And Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 182. North America Influenza Drugs And Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 183. Europe Influenza Drugs And Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 184. Europe Influenza Drugs And Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 185. Asia Pacific Influenza Drugs And Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 186. Asia Pacific Influenza Drugs And Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 187. South America Influenza Drugs And Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 188. South America Influenza Drugs And Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 189. Middle East and Africa Influenza Drugs And Vaccines Sales Forecast by Country (2026-2033) & (Units)
Table 190. Middle East and Africa Influenza Drugs And Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 191. Global Influenza Drugs And Vaccines Sales Forecast by Type (2026-2033) & (K MT)
Table 192. Global Influenza Drugs And Vaccines Market Size Forecast by Type (2026-2033) & (M USD)
Table 193. Global Influenza Drugs And Vaccines Price Forecast by Type (2026-2033) & (USD/KG)
Table 194. Global Influenza Drugs And Vaccines Sales (K MT) Forecast by Application (2026-2033)
Table 195. Global Influenza Drugs And Vaccines Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Influenza Drugs And Vaccines Market Size Comparison by Region (M USD)
Table 5. Global Influenza Drugs And Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Influenza Drugs And Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Influenza Drugs And Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Influenza Drugs And Vaccines Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Drugs And Vaccines as of 2024)
Table 10. Global Market Influenza Drugs And Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Influenza Drugs And Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Influenza Drugs And Vaccines Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Influenza Drugs And Vaccines Sales by Type (K MT)
Table 26. Global Influenza Drugs And Vaccines Market Size by Type (M USD)
Table 27. Global Influenza Drugs And Vaccines Sales (K MT) by Type (2020-2025)
Table 28. Global Influenza Drugs And Vaccines Sales Market Share by Type (2020-2025)
Table 29. Global Influenza Drugs And Vaccines Market Size (M USD) by Type (2020-2025)
Table 30. Global Influenza Drugs And Vaccines Market Size Share by Type (2020-2025)
Table 31. Global Influenza Drugs And Vaccines Price (USD/KG) by Type (2020-2025)
Table 32. Global Influenza Drugs And Vaccines Sales (K MT) by Application
Table 33. Global Influenza Drugs And Vaccines Market Size by Application
Table 34. Global Influenza Drugs And Vaccines Sales by Application (2020-2025) & (K MT)
Table 35. Global Influenza Drugs And Vaccines Sales Market Share by Application (2020-2025)
Table 36. Global Influenza Drugs And Vaccines Market Size by Application (2020-2025) & (M USD)
Table 37. Global Influenza Drugs And Vaccines Market Share by Application (2020-2025)
Table 38. Global Influenza Drugs And Vaccines Sales Growth Rate by Application (2020-2025)
Table 39. Global Influenza Drugs And Vaccines Sales by Region (2020-2025) & (K MT)
Table 40. Global Influenza Drugs And Vaccines Sales Market Share by Region (2020-2025)
Table 41. Global Influenza Drugs And Vaccines Market Size by Region (2020-2025) & (M USD)
Table 42. Global Influenza Drugs And Vaccines Market Size Market Share by Region (2020-2025)
Table 43. North America Influenza Drugs And Vaccines Sales by Country (2020-2025) & (K MT)
Table 44. North America Influenza Drugs And Vaccines Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Influenza Drugs And Vaccines Sales by Country (2020-2025) & (K MT)
Table 46. Europe Influenza Drugs And Vaccines Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Influenza Drugs And Vaccines Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Influenza Drugs And Vaccines Market Size by Region (2020-2025) & (M USD)
Table 49. South America Influenza Drugs And Vaccines Sales by Country (2020-2025) & (K MT)
Table 50. South America Influenza Drugs And Vaccines Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Influenza Drugs And Vaccines Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Influenza Drugs And Vaccines Market Size by Region (2020-2025) & (M USD)
Table 53. Global Influenza Drugs And Vaccines Production (K MT) by Region(2020-2025)
Table 54. Global Influenza Drugs And Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Influenza Drugs And Vaccines Revenue Market Share by Region (2020-2025)
Table 56. Global Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Influenza Drugs And Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. CSL Basic Information
Table 62. CSL Influenza Drugs And Vaccines Product Overview
Table 63. CSL Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. CSL Business Overview
Table 65. CSL SWOT Analysis
Table 66. CSL Recent Developments
Table 67. Bristol Myers Squibb Basic Information
Table 68. Bristol Myers Squibb Influenza Drugs And Vaccines Product Overview
Table 69. Bristol Myers Squibb Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Bristol Myers Squibb Business Overview
Table 71. Bristol Myers Squibb SWOT Analysis
Table 72. Bristol Myers Squibb Recent Developments
Table 73. AstraZeneca Basic Information
Table 74. AstraZeneca Influenza Drugs And Vaccines Product Overview
Table 75. AstraZeneca Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. AstraZeneca Business Overview
Table 77. AstraZeneca SWOT Analysis
Table 78. AstraZeneca Recent Developments
Table 79. Eli Lilly Basic Information
Table 80. Eli Lilly Influenza Drugs And Vaccines Product Overview
Table 81. Eli Lilly Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Eli Lilly Business Overview
Table 83. Eli Lilly Recent Developments
Table 84. Roche Basic Information
Table 85. Roche Influenza Drugs And Vaccines Product Overview
Table 86. Roche Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Roche Business Overview
Table 88. Roche Recent Developments
Table 89. GlaxoSmithKline Basic Information
Table 90. GlaxoSmithKline Influenza Drugs And Vaccines Product Overview
Table 91. GlaxoSmithKline Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Recent Developments
Table 94. Novartis Basic Information
Table 95. Novartis Influenza Drugs And Vaccines Product Overview
Table 96. Novartis Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Novartis Business Overview
Table 98. Novartis Recent Developments
Table 99. Pfizer Basic Information
Table 100. Pfizer Influenza Drugs And Vaccines Product Overview
Table 101. Pfizer Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. Sanofi Basic Information
Table 105. Sanofi Influenza Drugs And Vaccines Product Overview
Table 106. Sanofi Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Sanofi Business Overview
Table 108. Sanofi Recent Developments
Table 109. Bayer Basic Information
Table 110. Bayer Influenza Drugs And Vaccines Product Overview
Table 111. Bayer Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Bayer Business Overview
Table 113. Bayer Recent Developments
Table 114. Celgene Basic Information
Table 115. Celgene Influenza Drugs And Vaccines Product Overview
Table 116. Celgene Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Celgene Business Overview
Table 118. Celgene Recent Developments
Table 119. Seqirus Basic Information
Table 120. Seqirus Influenza Drugs And Vaccines Product Overview
Table 121. Seqirus Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Seqirus Business Overview
Table 123. Seqirus Recent Developments
Table 124. Protein Sciences Corporation Basic Information
Table 125. Protein Sciences Corporation Influenza Drugs And Vaccines Product Overview
Table 126. Protein Sciences Corporation Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Protein Sciences Corporation Business Overview
Table 128. Protein Sciences Corporation Recent Developments
Table 129. Serum Institute of India Basic Information
Table 130. Serum Institute of India Influenza Drugs And Vaccines Product Overview
Table 131. Serum Institute of India Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 132. Serum Institute of India Business Overview
Table 133. Serum Institute of India Recent Developments
Table 134. Emergent Biosolutions Basic Information
Table 135. Emergent Biosolutions Influenza Drugs And Vaccines Product Overview
Table 136. Emergent Biosolutions Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 137. Emergent Biosolutions Business Overview
Table 138. Emergent Biosolutions Recent Developments
Table 139. BioCryst Pharmaceuticals Basic Information
Table 140. BioCryst Pharmaceuticals Influenza Drugs And Vaccines Product Overview
Table 141. BioCryst Pharmaceuticals Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 142. BioCryst Pharmaceuticals Business Overview
Table 143. BioCryst Pharmaceuticals Recent Developments
Table 144. Alvogen Basic Information
Table 145. Alvogen Influenza Drugs And Vaccines Product Overview
Table 146. Alvogen Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 147. Alvogen Business Overview
Table 148. Alvogen Recent Developments
Table 149. Viatris Basic Information
Table 150. Viatris Influenza Drugs And Vaccines Product Overview
Table 151. Viatris Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 152. Viatris Business Overview
Table 153. Viatris Recent Developments
Table 154. Hulan Bio Basic Information
Table 155. Hulan Bio Influenza Drugs And Vaccines Product Overview
Table 156. Hulan Bio Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 157. Hulan Bio Business Overview
Table 158. Hulan Bio Recent Developments
Table 159. Changchun Institute of Biological Basic Information
Table 160. Changchun Institute of Biological Influenza Drugs And Vaccines Product Overview
Table 161. Changchun Institute of Biological Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 162. Changchun Institute of Biological Business Overview
Table 163. Changchun Institute of Biological Recent Developments
Table 164. Jiangsu GDK Basic Information
Table 165. Jiangsu GDK Influenza Drugs And Vaccines Product Overview
Table 166. Jiangsu GDK Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 167. Jiangsu GDK Business Overview
Table 168. Jiangsu GDK Recent Developments
Table 169. Sinovac Basic Information
Table 170. Sinovac Influenza Drugs And Vaccines Product Overview
Table 171. Sinovac Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 172. Sinovac Business Overview
Table 173. Sinovac Recent Developments
Table 174. Beike Bio Basic Information
Table 175. Beike Bio Influenza Drugs And Vaccines Product Overview
Table 176. Beike Bio Influenza Drugs And Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 177. Beike Bio Business Overview
Table 178. Beike Bio Recent Developments
Table 179. Global Influenza Drugs And Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 180. Global Influenza Drugs And Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 181. North America Influenza Drugs And Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 182. North America Influenza Drugs And Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 183. Europe Influenza Drugs And Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 184. Europe Influenza Drugs And Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 185. Asia Pacific Influenza Drugs And Vaccines Sales Forecast by Region (2026-2033) & (K MT)
Table 186. Asia Pacific Influenza Drugs And Vaccines Market Size Forecast by Region (2026-2033) & (M USD)
Table 187. South America Influenza Drugs And Vaccines Sales Forecast by Country (2026-2033) & (K MT)
Table 188. South America Influenza Drugs And Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 189. Middle East and Africa Influenza Drugs And Vaccines Sales Forecast by Country (2026-2033) & (Units)
Table 190. Middle East and Africa Influenza Drugs And Vaccines Market Size Forecast by Country (2026-2033) & (M USD)
Table 191. Global Influenza Drugs And Vaccines Sales Forecast by Type (2026-2033) & (K MT)
Table 192. Global Influenza Drugs And Vaccines Market Size Forecast by Type (2026-2033) & (M USD)
Table 193. Global Influenza Drugs And Vaccines Price Forecast by Type (2026-2033) & (USD/KG)
Table 194. Global Influenza Drugs And Vaccines Sales (K MT) Forecast by Application (2026-2033)
Table 195. Global Influenza Drugs And Vaccines Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Influenza Drugs And Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Drugs And Vaccines Market Size (M USD), 2024-2033
Figure 5. Global Influenza Drugs And Vaccines Market Size (M USD) (2020-2033)
Figure 6. Global Influenza Drugs And Vaccines Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Drugs And Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Drugs And Vaccines Product Life Cycle
Figure 13. Influenza Drugs And Vaccines Sales Share by Manufacturers in 2024
Figure 14. Global Influenza Drugs And Vaccines Revenue Share by Manufacturers in 2024
Figure 15. Influenza Drugs And Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Influenza Drugs And Vaccines Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Drugs And Vaccines Revenue in 2024
Figure 18. Industry Chain Map of Influenza Drugs And Vaccines
Figure 19. Global Influenza Drugs And Vaccines Market PEST Analysis
Figure 20. Global Influenza Drugs And Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Drugs And Vaccines Market Share by Type
Figure 27. Sales Market Share of Influenza Drugs And Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Drugs And Vaccines by Type in 2024
Figure 29. Market Size Share of Influenza Drugs And Vaccines by Type (2020-2025)
Figure 30. Market Size Share of Influenza Drugs And Vaccines by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Drugs And Vaccines Market Share by Application
Figure 33. Global Influenza Drugs And Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Drugs And Vaccines Sales Market Share by Application in 2024
Figure 35. Global Influenza Drugs And Vaccines Market Share by Application (2020-2025)
Figure 36. Global Influenza Drugs And Vaccines Market Share by Application in 2024
Figure 37. Global Influenza Drugs And Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Drugs And Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Drugs And Vaccines Market Size Market Share by Region (2020-2025)
Figure 40. North America Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza Drugs And Vaccines Sales Market Share by Country in 2024
Figure 43. North America Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Drugs And Vaccines Market Size Market Share by Country in 2024
Figure 45. U.S. Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Drugs And Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Drugs And Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Drugs And Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Drugs And Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza Drugs And Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Drugs And Vaccines Market Size Market Share by Country in 2024
Figure 55. Germany Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Drugs And Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza Drugs And Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Drugs And Vaccines Market Size Market Share by Region in 2024
Figure 68. China Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Drugs And Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Influenza Drugs And Vaccines Sales Market Share by Country in 2024
Figure 80. South America Influenza Drugs And Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Drugs And Vaccines Market Size Market Share by Country in 2024
Figure 82. Brazil Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Drugs And Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza Drugs And Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Drugs And Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Drugs And Vaccines Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Drugs And Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Drugs And Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza Drugs And Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza Drugs And Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza Drugs And Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza Drugs And Vaccines Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Influenza Drugs And Vaccines Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Influenza Drugs And Vaccines Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Influenza Drugs And Vaccines Market Share Forecast by Type (2026-2033)
Figure 111. Global Influenza Drugs And Vaccines Sales Forecast by Application (2026-2033)
Figure 112. Global Influenza Drugs And Vaccines Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Influenza Drugs And Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Influenza Drugs And Vaccines Market Size (M USD), 2024-2033
Figure 5. Global Influenza Drugs And Vaccines Market Size (M USD) (2020-2033)
Figure 6. Global Influenza Drugs And Vaccines Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Influenza Drugs And Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Influenza Drugs And Vaccines Product Life Cycle
Figure 13. Influenza Drugs And Vaccines Sales Share by Manufacturers in 2024
Figure 14. Global Influenza Drugs And Vaccines Revenue Share by Manufacturers in 2024
Figure 15. Influenza Drugs And Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Influenza Drugs And Vaccines Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Influenza Drugs And Vaccines Revenue in 2024
Figure 18. Industry Chain Map of Influenza Drugs And Vaccines
Figure 19. Global Influenza Drugs And Vaccines Market PEST Analysis
Figure 20. Global Influenza Drugs And Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Influenza Drugs And Vaccines Market Share by Type
Figure 27. Sales Market Share of Influenza Drugs And Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Influenza Drugs And Vaccines by Type in 2024
Figure 29. Market Size Share of Influenza Drugs And Vaccines by Type (2020-2025)
Figure 30. Market Size Share of Influenza Drugs And Vaccines by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Influenza Drugs And Vaccines Market Share by Application
Figure 33. Global Influenza Drugs And Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Influenza Drugs And Vaccines Sales Market Share by Application in 2024
Figure 35. Global Influenza Drugs And Vaccines Market Share by Application (2020-2025)
Figure 36. Global Influenza Drugs And Vaccines Market Share by Application in 2024
Figure 37. Global Influenza Drugs And Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Influenza Drugs And Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Influenza Drugs And Vaccines Market Size Market Share by Region (2020-2025)
Figure 40. North America Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Influenza Drugs And Vaccines Sales Market Share by Country in 2024
Figure 43. North America Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Influenza Drugs And Vaccines Market Size Market Share by Country in 2024
Figure 45. U.S. Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Influenza Drugs And Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Influenza Drugs And Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Influenza Drugs And Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Influenza Drugs And Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Influenza Drugs And Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Influenza Drugs And Vaccines Market Size Market Share by Country in 2024
Figure 55. Germany Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Influenza Drugs And Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Influenza Drugs And Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Influenza Drugs And Vaccines Market Size Market Share by Region in 2024
Figure 68. China Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Influenza Drugs And Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Influenza Drugs And Vaccines Sales Market Share by Country in 2024
Figure 80. South America Influenza Drugs And Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Influenza Drugs And Vaccines Market Size Market Share by Country in 2024
Figure 82. Brazil Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Influenza Drugs And Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Influenza Drugs And Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Influenza Drugs And Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Influenza Drugs And Vaccines Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Influenza Drugs And Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Influenza Drugs And Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Influenza Drugs And Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Influenza Drugs And Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Influenza Drugs And Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Influenza Drugs And Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Influenza Drugs And Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Influenza Drugs And Vaccines Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Influenza Drugs And Vaccines Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Influenza Drugs And Vaccines Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Influenza Drugs And Vaccines Market Share Forecast by Type (2026-2033)
Figure 111. Global Influenza Drugs And Vaccines Sales Forecast by Application (2026-2033)
Figure 112. Global Influenza Drugs And Vaccines Market Share Forecast by Application (2026-2033)
